Biological reactive intermediates that mediate dacarbazine cytotoxicityPOURAHMAD, Jalal; AMIRMOSTOFIAN, Marzieh; KOBARFARD, Farzad et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 1, pp 89-96, issn 0344-5704, 8 p.Article

Re-evaluating the role of dacarbazine in metastatic melanoma : What have we learned in 30 years?EGGERMONT, Alexander M. M; KIRKWOOD, John M.European journal of cancer (1990). 2004, Vol 40, Num 12, pp 1825-1836, issn 0959-8049, 12 p.Article

Modes of actions of two types of anti-neoplastic drugs, dacarbazine and ACNU, to induce apoptosisSANADA, Masayuki; HIDAKA, Masumi; TAKAGI, Yasumitsu et al.Carcinogenesis (New York. Print). 2007, Vol 28, Num 12, pp 2657-2663, issn 0143-3334, 7 p.Article

Dacarbazine : Déticène® = Dacarbazine : Deticene®QUEREUX, G; BROCARD, A; DRENO, B et al.Annales de dermatologie et de vénéréologie. 2007, Vol 134, Num 12, pp 1001-1003, issn 0151-9638, 3 p.Article

Fotosensibilidad por dacarbacina (DTIC) = Dacarbazine [DTIC]-induced photosensitivity reactionFERNANDEZ DE VILLATA, Maria José G; RUIZ-GENAO, Diana; SANCHEZ-PEREZ, Javier et al.Actas dermo-sifiliográficas (Ed. impresa). 2003, Vol 94, Num 8, pp 549-551, issn 0001-7310, 3 p.Article

Interaction of Dacarbazine and Imexon, In Vitro and In Vivo, in Human A375 Melanoma CellsSAMULITIS, Betty K; DORR, Robert T; CHOW, H.-H. Sherry et al.Anticancer research. 2011, Vol 31, Num 9, pp 2781-2785, issn 0250-7005, 5 p.Article

Mechanism of UVA-dependent DNA Damage Induced by An Antitumor Drug Dacarbazine in Relation to its PhotogenotoxicityIWAMOTO, Takuya; HIRAKU, Yusuke; OKUDA, Masahiro et al.Pharmaceutical research. 2008, Vol 25, Num 3, pp 598-604, issn 0724-8741, 7 p.Article

Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivoLEV, Dina Chelouche; ONN, Amir; MELINKOVA, Vladislava O et al.Journal of clinical oncology. 2004, Vol 22, Num 11, pp 2092-2100, issn 0732-183X, 9 p.Article

TREATMENT OF ADVANCED MALIGNANT HEMANGIOPERICYTOMA WITH COMBINATION ADRIAMYCIN AND DTIC: A REPORT OF FOUR CASES = TRAITEMENT DES HEMANGIOPERICYTOMES MALINS AVANCES PAR ASSOCIATION D'ADRIAMYCINE ET DE DTIC: A PROPOS DE QUATRE CASBEADLE GF; HILLCOAT BL.1983; JOURNAL OF SURGICAL ONCOLOGY; ISSN 0022-4790; USA; DA. 1983; VOL. 22; NO 3; PP. 167-170; ABS. ENG; BIBL. 19 REF.Article

PHOTOSENSITIVITY REACTION FOLLOWING DTIC ADMINISTRATION: REPORT OF TWO CASESBECK TM; HART NE; SMITH CE et al.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 4-5; PP. 725-726; BIBL. 5 REF.Article

EFFECTIVE TREATMENT OF KAPOSI'S SARCOMA WITH 5-(3,3-DIMETHYL-1-TRIAZENO) IMIDAZOLE-4-CARBOXAMIDE (NSC-45388)VOGEL CL; PRIMACK A; OWOR R et al.1973; CANCER CHEMOTHERAPY REP., I; U.S.A.; DA. 1973; VOL. 57; NO 1; PP. 65-71; BIBL. 12REF.Serial Issue

Phase I―II study of plitidepsin and dacarbazine as first-line therapy for advanced melanomaPLUMMER, R; LORIGAN, P; KAHATT, C et al.British journal of cancer. 2013, Vol 109, Num 6, pp 1451-1459, issn 0007-0920, 9 p.Article

5-(3,3-DIMETHYL-1-TRIAZENO) IMIDAZOLE-4-CARBOXAMIDE (NSC-45388) IN THE TREATMENT OF SOLID TUMORS IN CHILDRENFINKLESTEIN JZ; ALBO V; ERTEL I et al.1975; CANCER CHEMOTHERAPY REP.; U.S.A.; DA. 1975; VOL. 59; NO 2; PP. 351-357; BIBL. 8 REF.Article

DTIC (NSC-45388) TOXICITYMOORE GE; MEISELBAUGH D.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 3; PP. 219Article

Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma : The oblimersen melanoma study groupBEDIKIAN, Agop Y; MILLWARD, Michael; KIRKWOOD, John M et al.Journal of clinical oncology. 2006, Vol 24, Num 29, pp 4738-4745, issn 0732-183X, 8 p.Article

Study of the alkylation behaviors of antitumor agents to DNA using a quartz crystal resonator in PEG-DNA solutionLIN, Z.-H; SHEN, G.-L; LIN, Y et al.Fresenius' journal of analytical chemistry. 1997, Vol 357, Num 7, pp 921-926, issn 0937-0633Article

A Phase 1-2 Study of Imexon Plus Dacarbazine in Patients With Unresectable Metastatic MelanomaWEBER, Jeffrey S; SAMLOWSKI, Wolfram E; GONZALEZ, Rene et al.Cancer. 2010, Vol 116, Num 15, pp 3683-3691, issn 0008-543X, 9 p.Article

CD69 on CD56+ NK cells and response to chemoimmunotherapy in metastatic melanomaKONJEVIC, G; JOVIC, V; VULETIC, A et al.European journal of clinical investigation. 2007, Vol 37, Num 11, pp 887-896, issn 0014-2972, 10 p.Article

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic MelanomaROBERT, Caroline; THOMAS, Luc; DAVIDSON, Neville et al.The New England journal of medicine. 2011, Vol 364, Num 26, pp 2517-2526, issn 0028-4793, 10 p.Article

Combination of Dacarbazine and Dimethylfumarate Efficiently Reduces Melanoma Lymph Node MetastasisVALERO, Teresa; STEELE, Silvia; NEUMÜLLER, Karin et al.Journal of investigative dermatology. 2010, Vol 130, Num 4, pp 1087-1094, issn 0022-202X, 8 p.Article

Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: A phase III studyAVRIL, M. F; AAMDAL, S; PORTA, V. Guillem et al.Journal of clinical oncology. 2004, Vol 22, Num 6, pp 1118-1125, issn 0732-183X, 8 p.Article

Chemotherapeutic induced fascial oedemaLIM, I; KEFFORD, R; MANOLIOS, N et al.Annals of the rheumatic diseases. 2005, Vol 64, Num 1, pp 162-163, issn 0003-4967, 2 p.Article

Killing and mutagenic actions of dacarbazine, a chemotherapeutic alkylating agent, on human and mouse cells: effects of Mgmt and Mlh1 mutationsSANADA, Masayuki; TAKAEI, Yasumitsu; ITO, Riyoko et al.DNA repair. 2004, Vol 3, Num 4, pp 413-420, issn 1568-7864, 8 p.Article

Stability of dacarbazine in amber glass vials and polyvinyl chloride bagsEL AATMANI, Mohamed; POUJOL, Sylvain; ASTRE, Cecile et al.American journal of health-system pharmacy. 2002, Vol 59, Num 14, pp 1351-1356, issn 1079-2082Article

Melanoma erysipeloides : successful treatment by chemoimmunotherapyHILLEN, U; WILLERS, C; GOOS, M et al.British journal of dermatology (1951). 2000, Vol 143, Num 4, pp 904-906, issn 0007-0963Article